Literature DB >> 3379128

Operating characteristics of the hypothalamo-pituitary-gonadal axis in men: circadian, ultradian, and pulsatile release of prolactin and its temporal coupling with luteinizing hormone.

J D Veldhuis1, M L Johnson.   

Abstract

To investigate the circadian, ultradian, and pulsatile nature of PRL release in the human, we sampled blood at 10-min intervals for 24 h in each of 12 normal young men. The subsequent serum PRL time series were subjected to contemporary techniques of rhythmic and episodic peak detection. Fourier analysis revealed a significant circadian rhythm in serum PRL concentrations in all 12 men. The mean circadian amplitude was 2.1 +/- 0.3 ng/mL (micrograms/L), which accounted for an average of 30 +/- 4% of the 24-h mean PRL concentration. In addition, multiple ultradian PRL rhythms were found with periodicities ranging from 22-242 min. Spectral analysis disclosed ultradian cycles with periodicities of 30-32, 51-59, 90-98, and 234 min. Assessment of episodic PRL pulsatility by Cluster analysis revealed 14 +/- 1 PRL peaks/24 h (P less than 0.01 vs. signal-free noise), which occurred at an interpulse interval of 95 +/- 6 min. The average duration of a serum PRL peak was 67 +/- 5 min, and its incremental amplitude was 4.0 +/- 0.3 ng/ml (micrograms/L), which represented a 58 +/- 6% increase above the preceding nadir. Discrete PRL peaks were separated by nonpulsatile valleys, with a mean duration of 27 +/- 1 min. Analysis of the temporal coupling between LH and PRL release by bivariate autoregressive modeling in six men revealed significant cross-correlations between LH and simultaneous PRL concentrations as well as between LH and PRL concentrations that lagged LH by 10 or 20 min. Cross-spectral analysis demonstrated significantly correlated PRL and LH cycles with periodicities of 33-37, 47-52, and 84-106 min. In summary, PRL release in normal young men is characterized by significant circadian and ultradian periodicities, by discrete episodic pulsations that occur approximately every 95 min, and by a close temporal coupling with LH (temporal lag between LH and PRL of 0-20 min).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3379128     DOI: 10.1210/jcem-67-1-116

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

Review 1.  Motivations and methods for analyzing pulsatile hormone secretion.

Authors:  Johannes D Veldhuis; Daniel M Keenan; Steven M Pincus
Journal:  Endocr Rev       Date:  2008-10-21       Impact factor: 19.871

2.  Amisulpride: Real-World Evidence of Dose Adaptation and Effect on Prolactin Concentrations and Body Weight Gain by Pharmacokinetic/Pharmacodynamic Analyses.

Authors:  Anaïs Glatard; Monia Guidi; Aurélie Delacrétaz; Céline Dubath; Claire Grosu; Nermine Laaboub; Armin von Gunten; Philippe Conus; Chantal Csajka; Chin B Eap
Journal:  Clin Pharmacokinet       Date:  2020-03       Impact factor: 6.447

Review 3.  Evidence for a Coupled Oscillator Model of Endocrine Ultradian Rhythms.

Authors:  Azure D Grant; Kathryn Wilsterman; Benjamin L Smarr; Lance J Kriegsfeld
Journal:  J Biol Rhythms       Date:  2018-08-22       Impact factor: 3.182

Review 4.  Control of prolactin secretion.

Authors:  G Benker; C Jaspers; G Häusler; D Reinwein
Journal:  Klin Wochenschr       Date:  1990-12-04

Review 5.  Current management of prolactinomas.

Authors:  P Nomikos; M Buchfelder; R Fahlbusch
Journal:  J Neurooncol       Date:  2001-09       Impact factor: 4.130

6.  Prolactin secretion in idiopathic hypogonadotropic hypogonadism during pulsatile luteinizing hormone-releasing hormone long-term administration.

Authors:  M Giusti; L Traverso; P Cavagnaro; R Torre; R Durante; G Giordano
Journal:  J Endocrinol Invest       Date:  1989-09       Impact factor: 4.256

7.  Hyperprolactinemia with antipsychotic drugs in children and adolescents.

Authors:  Arlan L Rosenbloom
Journal:  Int J Pediatr Endocrinol       Date:  2010-08-24

Review 8.  Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.

Authors:  Peter M Haddad; Angelika Wieck
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 9.  Hyperprolactinemia.

Authors:  Jaspreet Chahal; Janet Schlechte
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

10.  Importance of cannulated prolactin test in the definition of hyperprolactinaemia.

Authors:  M B Whyte; S Pramodh; L Srikugan; J A Gilbert; J P Miell; R A Sherwood; A M McGregor; S J B Aylwin
Journal:  Pituitary       Date:  2015-06       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.